Flash glucose monitoring (FGM): A clinical review on glycaemic outcomes and impact on quality of life

Ang, Eshen; Lee, Zong Xuan; Moore, Sacha; Nana, Melanie

doi:10.1016/j.jdiacomp.2020.107559

Cited by 50 publications

(50 citation statements)

References 52 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Regarding patients’ satisfaction, only four of the systematic reviews included assessed this variable [ 28 , 37 , 38 , 39 ], concluding that patients using FGM seemed to report a higher satisfaction than those using other glucose measuring tools. Nevertheless, some studies showed incomplete results for this variable, and the information reported does not allow us to evaluate the methods used to measure it.…”

Section: Discussionmentioning

confidence: 99%

“…This could be the reason for the scarcity of studies focused on the use of this technique. Additionally, some device-related adverse events have been described, such as erythema, rash, itching, pain, bleeding, oedema, induration or bruising [ 27 , 37 , 38 ]. In this regard, no evidence is available on whether these effects may negatively affect QoL or patients’ satisfaction.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Flash Glucose Monitoring and Patient Satisfaction: A Meta-Review of Systematic Reviews

Díez‐Fernández

Rodríguez-Huerta

Mirón-González

et al. 2021

IJERPH

View full text Add to dashboard Cite

Flash glucose monitoring (FGM) systems have been suggested to have clinical beneficial effects in patients with diabetes mellitus, although their improvements in terms of quality of life (QoL) and patients’ satisfaction are not always addressed or are considered a secondary outcome. Thus, the aim of this meta-review is to establish the benefits of FGM in terms of patients’ satisfaction and QoL in both type 1 and type 2 diabetes patients using evidence from past systematic reviews and meta-analyses. Major databases were searched for systematic reviews (with or without meta-analyses) that assessed the satisfaction or QoL of type 1 or 2 diabetes patients using FGM compared with other glucose monitoring systems. The quality of the included systematic reviews was addressed with the Assessment of Multiple Systematic Reviews 2 (AMSTAR-2) tool. Six systematic reviews (including two meta-analyses) were included in the meta-review. Evidence suggests that FGM systems seem to improve patients’ satisfaction and QoL compared with self-monitoring of blood glucose, although the high variability in the measurement tools, the clinical significance and the quality of the systematic reviews included do not allow us to state FGM benefits with any certainty. Further research, including high-quality randomised clinical trials, differentiating the needs of both type 1 and type 2 diabetes patients and focusing on psychosocial benefits for these patients is needed to optimise clinical decisions between patients and professionals by developing the right health technology assessment for FGM systems.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Flash Glucose Monitoring and Patient Satisfaction: A Meta-Review of Systematic Reviews

Díez‐Fernández

Rodríguez-Huerta

Mirón-González

et al. 2021

IJERPH

View full text Add to dashboard Cite

show abstract

“…Continuous glucose monitoring devices are costly, with inconsistent reimbursement across government bodies. 3,8,14 Many countries, including Australia and America, offer reimbursement for people with type 1 diabetes mellitus, with limited subsidisation for people with type 2 diabetes mellitus (S30,S31). Germany reimburses real-time CGM for all types of diabetes, whereas Spain offers no reimbursement at all (S30).…”

Section: Costmentioning

confidence: 99%

Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus

Lin

Brown²,

James

et al. 2021

Diabet Med

View full text Add to dashboard Cite

Abbreviations: DCCT, Diabetes Control and Complications Trial; GOLD, glycaemic control and optimisation of life quality in type 1 diabetes; DIAMOND, multiple daily injections and continuous glucose monitoring in diabetes; SWITCH, sensing with insulin pump therapy to control HbA 1c ; JDRF, Juvenile Diabetes Research Foundation; CITY, CGM intervention in teens and young adults with type 1 diabetes; WISDM, wireless innovation for seniors with diabetes mellitus; HypoDE, real-time continuous glucose monitoring in patients with type 1 diabetes at high risk for low glucose values using multiple daily injections in Germany; IN CONTROL, continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia; IMPACT, novel glucose-sending technology and hypoglycaemia in type 1 diabetes; SELFY, FreeStyle libre glucose monitoring system paediatric study; REPLACE, an evaluation of a novel glucose sensing technology in type 2 diabetes; GP-OSMOTIC, general practice optimising structured monitoring to improve clinical outcomes in type 2 diabetes.

show abstract

“…Real-time data provide immediate feedback regarding the impact of dietary choices, exercise, medication changes, and other life-variables. In contrast to the real-time CGM, Flash GM (FGM, also known as intermittently scanned CGM or isCGM) uses a sensor that must be scanned with a reader or smart device in order to retrieve the glucose data [32]. These systems do not currently include alarms that alert the PwD to trends of hypo-or hyperglycemia, although this capability is planned for future versions.…”

Section: Cgmmentioning

confidence: 99%

Making sense of glucose metrics in diabetes: linkage between postprandial glucose (PPG), time in range (TIR) & hemoglobin A1c (A1C)

Martens¹,

Bergenstal²,

Pearson³

et al. 2020

Postgraduate Medicine

View full text Add to dashboard Cite

Flash glucose monitoring (FGM): A clinical review on glycaemic outcomes and impact on quality of life

Cited by 50 publications

References 52 publications

Flash Glucose Monitoring and Patient Satisfaction: A Meta-Review of Systematic Reviews

Flash Glucose Monitoring and Patient Satisfaction: A Meta-Review of Systematic Reviews

Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus

Making sense of glucose metrics in diabetes: linkage between postprandial glucose (PPG), time in range (TIR) & hemoglobin A1c (A1C)

Contact Info

Product

Resources

About